
Hopes for robust, long-term antibody protection after a bout of COVID-19 have been dampened by a new study that finds the protection may only last a few months. Still, experts noted that the body’s immune system has more than one way to defend against viruses it has already encountered, so the findings don’t dash hopes for a vaccine. “Infection with this coronavirus does not necessarily generate lifetime immunity,” Dr. Buddy Creech, an infectious disease specialist at Vanderbilt University in Nashville, told the Associated Press. But antibodies are only part of the immune system’s armamentarium, added Creech, who wasn’t part of the new research. The study was published July 21 in the New England Journal of Medicine. Researchers led by Dr. Otto Yang, of the University of California, Los Angeles, sought to determine the “half-life” of antibodies generated by contact with the new SARS-CoV-2 virus. Half-life means the time it takes for half of the antibodies to disappear. Yang’s group took blood samples from 34 people who had all recovered from a mild case of COVID-19. Twenty were women and 14 were men, and they averaged 43 years of age. Based on blood tests collected up to 119 days after the onset of symptoms, the researchers said the half-life of antibodies linked with SARS-CoV-2 infection was just 36 days — just over a month. At that… read on >